Simulations Plus, Inc. logo

Simulations Plus, Inc.

NASDAQ:SLP

Overview | Financials
Company Name Simulations Plus, Inc.
Symbol SLP
Currency USD
Price 28.66
Market Cap 575,650,430
Dividend Yield 0.49%
52-week-range 27.07 - 51.22
Industry Health Information Services
Sector Healthcare
CEO Mr. Walter S. Woltosz M.A.S., M.S.
Website https://www.simulations-plus.com

An error occurred while fetching data.

About Simulations Plus, Inc.

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of

Related Stocks

Recursion Pharmaceuticals, Inc. logo

Recursion Pharmaceuticals, Inc.

RXRX

7.39 USD

SNDL Inc. logo

SNDL Inc.

SNDL

1.79 USD

Ventyx Biosciences, Inc. logo

Ventyx Biosciences, Inc.

VTYX

2.38 USD

BridgeBio Pharma, Inc. logo

BridgeBio Pharma, Inc.

BBIO

27.99 USD

Varex Imaging Corporation logo

Varex Imaging Corporation

VREX

14.82 USD

Financials

Numbers are in millions USD

Numbers are in millions USD